Abhijit Shaligram, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 891 W Main St, Suite 700, Dover Foxcroft, ME 04426 Phone: 207-564-4466 |
Pamela J.w. Nourse, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 891 W Main St, Suite 700, Dover Foxcroft, ME 04426 Phone: 207-564-4466 Fax: 207-564-4468 |
Dr. Richard A. Evans, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 14 Winter St, Dover Foxcroft, ME 04426 Phone: 207-564-0715 Fax: 207-564-0717 |
Narasimha Swamy, Surgery Medicare: Medicare Enrolled Practice Location: 891 W Main St, Suite 500, Dover Foxcroft, ME 04426 Phone: 207-564-4466 Fax: 207-564-1283 |
Dr. Ruth Ellen O'mahony, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 897 W Main St, Suite 700, Dover Foxcroft, ME 04426 Phone: 207-564-4466 |
Jeffrey Allen Cole, DO Surgery Medicare: Not Enrolled in Medicare Practice Location: 891 W Main St, Suite 700, Dover Foxcroft, ME 04426 Phone: 207-564-4466 Fax: 207-564-4468 |
News Archive
A new national report reveals that 45.9 million American adults aged 18 or older, or 20 percent of this age group, experienced mental illness in the past year. The rate of mental illness was more than twice as high among those aged 18 to 25 (29.9 percent) than among those aged 50 and older (14.3 percent). Adult women were also more likely than men to have experienced mental illness in the past year (23 percent versus 16.8 percent).
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
In a review of recent literature, a team of researchers from Kessler Foundation conclude that cognitive rehabilitation programs are efficacious in treating multiple sclerosis-related cognitive dysfunction, and urge clinicians to consider this low-cost, low-risk, yet effective treatment approach for their patients.
It sounds like science fiction: Nefarious genes clone themselves and settle their rogue copies in distant outposts of the galaxy (namely, our DNA), causing disease.
Also part of the special series, "Are You Covered?" Kaiser Health News and NPR report that "for two families, 'gold-plated' health insurance has made a huge difference in the health care they receive. But it's not always the rich who get these benefits, and they worry about what a possible tax on plans would do to their health coverage (Gold, 9/22).
› Verified 1 days ago